Share this article
Share this article
ResearchAndMarkets.com s offering.
The global CAR-T therapy market reached a value of nearly $734.0 million in 2019. The market is expected to grow from $734.0 million in 2019 to $2,250 million in 2023 at a rate of 32.3%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize and reach $3,150 million in 2025 and $6,100 million in 2030.
The CAR-T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat all types of cancers. This industry includes establishments that are involved in the research and development to introduce new targeted cell therapies for treating different blood related cancers.